Working… Menu
Trial record 1 of 15 for:    force rituximab
Previous Study | Return to List | Next Study

Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis (FORCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00774462
Recruitment Status : Completed
First Posted : October 17, 2008
Last Update Posted : December 11, 2012
Institut National de la Santé Et de la Recherche Médicale, France
Roche Pharma AG
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris